Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Beta-lapachone Highly Effective Against Non-small Cell Lung Cancer

By Biotechdaily staff writers
Posted on 18 Jul 2007
Print article
A recent report described the molecular mechanism used by the chemotherapeutic agent beta-lapachone to kill non-small cell lung cancer (NSCLC) tumors. NSCLC is one of the deadliest forms of cancer with a five-year survival rate of only about 15%.

Investigators at the University of Texas Southwestern Medical Center (Dallas, USA) studied the action of beta-lapachone on the enzyme NAD(P)H:quinone oxidoreductase-1 (NQO1). NQO1 is absent or nearly absent in normal tissues but highly expressed in NSCLC tumors.

Results published in the July 3, 2007, online edition of the Proceedings of the [U.S.] National Academy of Sciences revealed that NSCLC cells grown in tissue culture were killed by a high dose of beta-lapachone given for only two to four hours. Normal cells not expressing NQO1 were not damaged by the drug.

Beta-lapachone induced formation of active radicals that caused damage to the cancer cells' DNA while at the same time disrupting the cells' ability to repair their DNA (by inhibiting the DNA repair enzyme topoisomerase I), ultimately leading to the death of the cells. Since treating tumor cells with radiation also causes DNA damage, co-treatment with radiation and beta-lapachone was even more effective than treatment with the drug alone.

"When you irradiate a tumor, the levels of NQO1 go up,” said senior author Dr. David Boothman, professor of pharmacology and radiation oncology at the University of Texas Southwestern Medical Center. "When you then treat these cells with beta-lapachone, you get synergy between the enzyme and this agent and you get a whopping kill. Basically, we have worked out the mechanism of action of beta-lapachone and devised a way of using that drug for individualized therapy.”


Related Links:
University of Texas Southwestern Medical Center

Print article

Channels

Biochemistry

view channel
Image: A space-filling model of the anticonvulsant drug carbamazepine (Photo courtesy of Wikimedia Commons).

Wastewater May Contaminate Crops with Potentially Dangerous Pharmaceuticals

Reclaimed wastewater used to irrigate crops is contaminated with pharmaceutical residues that can be detected in the urine of those who consumed such produce. Investigators at the Hebrew University... Read more

Lab Technologies

view channel
Image: A three-dimensional printer adapted for stem cell production (Photo courtesy of Nano Dimension).

Israeli Developers Demonstrate Prototype Three-Dimensional Bioprinter

Two Israeli companies have combined efforts in the development of three-dimensional printer technology for the production of stem cells. The three-dimensional print electronics developer Nano Dimension... Read more

Business

view channel

Acquisition to Boost Development of Drugs for Neurogenic Conditions

According to a recent announcement, a privately held biotechnology/drug development company is to be acquired by one of the major pharmaceutical manufacturers. The drug manufacturer Merck & Co. (Kenilworth, NJ, USA) has agreed to pay 500 million USD up front for Afferent Pharmaceuticals (San Mateo, CA, USA) and up... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.